Global Bone Growth Stimulator Market Size to Reach USD 3.80 Billion in 2032 | Emergen Research

Increasing prevalence of osteoporosis and osteoarthritis is a key factor driving bone growth stimulator revenue growth

Vancouver, Sept. 13, 2023 (GLOBE NEWSWIRE) — The global bone growth stimulator market size was USD 2.22 Billion in 2022 and is expected to register a steady revenue CAGR of 5.5% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of Minimally Invasive Surgical (MIS) techniques and aging population and rising prevalence of osteoporosis are key factors driving market revenue growth.

A bone growth stimulator is an electrical stimulation treatment used to enhance bone healing in complicated fractures. This is an alternative therapy, which is mostly suggested by surgeons to speed up the healing process of fractures. In addition, availability of sophisticated and cutting-edge bone growth stimulators as well as rising public knowledge about advantages of bone growth stimulation therapy is another factor driving revenue growth of the market. Moreover, increasing expenditures in Research & Development (R&D) activities by major market players and availability of reimbursement for bone growth stimulation therapy are expected to drive market revenue growth during the forecast period. Furthermore, rising prevalence of orthopedic conditions including osteoarthritis, rising demand for non-invasive and non-pharmacological bone healing treatments,  and increasing use of bone growth stimulators in sports medicine and military medicine are also driving revenue growth of the market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1373

Availability of substitutes to bone growth stimulators is one of the major factor restraining revenue growth of the market. Treatments, such as traditional physiotherapy, yoga, or Ayurveda, are frequently suggested for bone fractures that do not heal or heal slowly. In addition, chiropractic is utilized to identify and treat mechanical musculoskeletal system abnormalities.

Scope of Research

Report Details Outcome
Market Size in 2022 USD 2.22 Billion
CAGR (2022–2030) 5.5%
Revenue Forecast to 2032 USD 3.80 Billion
Base Year for Estimation 2022
Historical Data 2019–2021
Forecast Period 2023–2032
Quantitative Units Revenue in USD Billion and CAGR in % from 2023 to 2032
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered Modality, application, and region
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country Scope U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies Profiled Isto Biologics, Johnson And Johnson, MEDTRONIC PLC., Orthofix Medical Inc., STRYKER CORPORATION, Terumo Corporation, ZIMMER BIOMET HOLDINGS, IGEA Pharma, Manamed Inc., and THERAGEN ETEX CO., LTD
Customization Scope 10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1373

Major Companies and Competitive Landscape

The global bone growth stimulator market is fragmented with large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective products. Some of the major companies included in the global bone growth stimulator market report are:

  • Isto Biologics
  • Johnson and Johnson
  • MEDTRONIC PLC.
  • Orthofix Medical Inc.
  • STRYKER CORPORATION
  • Terumo Corporation
  • ZIMMER BIOMET HOLDINGS
  • IGEA Pharma
  • Manamed Inc.
  • THERAGEN ETEX CO., LTD.

Strategic Development

  • On 4 May, 2022, AccelStimTM bone healing therapy Class III device has received pre-market approval from the U.S. Food and Drug Administration (FDA). For recommended acute fractures and fractures that have not healed, AccelStim device offers a secure and reliable nonsurgical treatment (nonunions). This gadget produces a Low-Intensity Pulsed Ultrasound (LIPUS) signal that stimulates bone’s natural healing process to speed up the healing of fractures.
  • On 18 August, 2022, Theragen, a manufacturer of medical devices, announced the receipt of a U.S. Patent for its novel method of creating ActaStim-S spine fusion bone growth stimulator system

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1373

Some Key Highlights from the Report

  • The bone growth stimulation devices segment is expected to register a steadily fast revenue growth rate over the forecast period. Demand for these devices to treat non-union fractures and spinal fusion operations is rising, which is further driving market revenue growth. In addition, increasing expenditures in R&D activities by major market players as well as availability of reimbursement for bone growth stimulation therapy is expected to drive market revenue growth during the forecast period.  Moreover, market revenue growth is also expected to drive owing to rising prevalence of orthopedic ailments including osteoarthritis and rising need for non-invasive and non-pharmacological bone healing treatments.
  • The spinal fusion surgeries segment is expected to account for a significant revenue share over the forecast period.  This is due to rising prevalence of spinal illnesses and expanding use of minimally invasive surgical techniques. In addition, increasing frequency of persistent low back pain and degenerative spinal disorders rising and demand for spinal fusion surgeries are also driving market revenue growth.
  • The North America market is expected to register a significantly fast revenue growth rate during the forecast period.  This is due to aging population, increasing osteoporosis cases, and rising use of minimally invasive surgical techniques. Use of these devices to treat non-union fractures and spinal fusion operations is increasing, which is further driving market revenue growth in this region.
  • On 20 December, 2022, Essent Biologics, a major provider of human-derived cell and scaffold materials,  introduced its novel Micronized Bone Matrix (MBM) for use in 3D bioprinting and tissue engineering. Essent Biologics will offer a mineralized allograft bone matrix, which includes native proteins such as collagen type I, as well as native elements and minerals including calcium and phosphorus, using pulverized cortical bone from humans.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/bone-growth-stimulator-market

Emergen Research has segmented the global bone growth stimulator market based on modality, application, and region:

  • Modality Outlook (Revenue, USD Billion; 2019-2032)
    • Bone Growth Stimulation Devices
    • Bone Morphogenetic Proteins
    • Platelet-Rich Plasma
  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Spinal Fusion Surgeries
    • Delayed Union and Nonunion Bone Fractures
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Cell and Gene Therapy Market By Indication (Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-Cell Lymphoma, ADA-SCID), By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Modified Herpes Simplex Virus, Adenovirus, Non-Viral Plasmid Vector), Forecasts to 2027
Joint Reconstruction Devices Market By Type (Knee, Hip, Shoulder, Ankle), By Technique (Joint replacement, Osteotomy, Arthroscopy, Resurfacing), By Application (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers), Forecasts to 2027
Operating Room Integration Systems Market By Device Type (Audio Video Management System, Display System, Documentation Management System), By End-Use, By Application (General Surgery, Orthopedic Surgery, Neurosurgery), Forecasts to 2027

Companion Diagnostics Market By Technology (Immunohistochemistry, In Situ Hybridization, Polymerase Chain Reaction, Genetic Sequencing), By Disease Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer), By Application (Hospitals, Diagnostic Laboratories), By Region, Forecasts to 2017-2027

Precision Medicine Market By Technology (Big-Data Analytics and Bioinformatics), By Application (Oncology and CNS), By End-Use (Pharmaceutical Companies and Healthcare IT Companies), and By Region Forecast to 2030

Cell Culture Market Size, Share, Trends, By Consumables (Media, Sera, Reagents), By Product (Culture Systems, Incubators, Centrifuges, Pipetting Instruments, Biosafety Equipment, Cryostorage Equipment), By Application, Forecasts to 2027

Liquid Biopsy Market, By Product Type (Assays Kits, Instruments, Services), By Circulating Biomarkers, By Sample Type, By Technology, By Disease, By Application, By End-Use, and By Region Forecast to 2030

Microfluidics Market, By Material Type (Polymer, Silicon, Glass, Others), By Application (Point-of-Care Testing, Drug Delivery Systems, Others), By Components (Microfluidic Chips, Micropumps, Microneedles, Others), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Bone Growth Stimulator Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-bone-growth-stimulator-market

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy